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There is an increasing recognition that bipolar disorder
is associated with elevated mortality and morbidity
rates. Although there are still some doubts whether
schizophrenia impairs physical health more than other
disorders, recent papers [1,2] have demonstrated that
bipolar disorder impairs metabolic and cardiovascular
systems as much as schizophrenia.
Reported prevalence of metabolic syndrome (MetS) in
patients with bipolar disorder varies from 18% to 32% in
the European Union (EU) and 40% to 49% in the United
States of America (USA). These rates are substantially
higher than that reported for the general population
(15% EU, 27% USA) [3], and very similar to that
reported for patients with schizophrenia (19.4% to
44.7%). Much less attention has been paid to cardiovas-
cular risks in these patients. Two recently published stu-
dies [1,4] demonstrated higher cardiovascular risk level
than the general population. Furthermore, the Spanish
study [4] demonstrated that Spanish patients with bipo-
lar disorder were exposed to the same cardiovascular
risk level as Spanish patients with schizophrenia.
Unpublished data from our comparative study on phy-
sical health in patients with bipolar disorder versus
patients with schizophrenia shown that bipolar disorder
impairs physical health even more than schizophrenia.
There were not statistical significant differences accord-
ing to diagnosis neither in MetS rates (21.4% of patients
with bipolar disorder versus 28.7% of patients with schi-
zophrenia, p 0.315), nor in the mean body mass index
(bipolar = 30.3 versus schizophrenia = 30 kg/m2,
p 0.723), or in the BMI categories (obesity: bipolar =
43.4% versus schizophrenia = 43%, p 0.964). However,
patients with bipolar disorder reported greater proportion
of hypertension than patients with schizophrenia (19.6%
versus 6.2%, p 0.008) and met criterion 4 -elevated blood
pressure- for MetS in a greater proportion too (35.7%
versus 13.8%, p = .001).
Psychiatrists must be aware of these facts and carefully
monitor and control patients with bipolar disorder for
components of MetS and risk factors of cardiovascular
diseases as part of the standard of care when treating
these patients. Furthermore, specific programs should be
implemented for patients with bipolar disorder aimed at
reducing cigarette smoking, increasing exercise, and
improving dietary habits.
Published: 22 April 2010
References
1. Birkenaes AB, Opjordsmoen S, Brunborg C, Engh JA, Jonsdottir H,
Ringen PA, Simonsen C, Vaskinn A, Birkeland KI, Friis S, Sundet K,
Andreassen OA: The level of cardiovascular risk factors in bipolar
disorder equals that of schizophrenia: a comparative study. J Clin
Psychiatry 2007, 68:917-23.
2. Correll CU, Frederickson AM, Kane JM, Manu P: Equally increased risk for
metabolic syndrome in patients with bipolar disorder and schizophrenia
treated with second-generation antipsychotics. Bipolar Disord 2008,
10:1-10.
3. Garcia-Portilla MP, Saiz PA, Benabarre A, Sierra P, Perez J, Rodriguez A,
Livianos L, Torres P, Bobes J: The prevalence of metabolic syndrome in
patients with bipolar disorder. J Affect Disord 2008, 106:197-201.
4. Garcia-Portilla MP, Saiz PA, Bascaran MT, Martínez S, Benabarre A, Sierra P,
Torres P, Montes JM, Bousoño M, Bobes J, on behalf of the General Health
Status in Bipolar Disorder Collaborative Group: Cardiovascular risk in
patients with bipolar disorder. J Affect Disord 2009, 115:302-308.
doi:10.1186/1744-859X-9-S1-S32
Cite this article as: Bobes: The general problem of increased somatic
comorbidity in bipolar patients. Annals of General Psychiatry 2010
9(Suppl 1):S32.
University of Oviedo, (Asturias) and Psychiatric Services for the Oviedo Area,
Spain
Bobes Annals of General Psychiatry 2010,
9(Suppl 1):S32
http://www.annals-general-psychiatry.com/content/9/S1/S32
© 2009 Bobes; licensee BioMed Central Ltd.